HIV-1-specific CD8+ T cells are associated with declining viremia in acute primary infection and control of viral replication in long-term non-progressive infection, but neither their magnitude nor breadth correlates with control of viremia in chronic progressive infection, suggesting a functional defect of these cells that is not measured by interferon-g secretion assays commonly used. In addition, a series of previous studies indicated that the antigen-specific secretion of TNF-a and MIP-1b or antigen-specific degranulation in HIV-1- specific CD8+ T cells are also not correlated with protective immunity against HIV-1. The definition of functional properties of HIV-1-specific CD8+ T cells that are associated with protection against HIV-1 disease progression is therefore of primary importance for the design of HIV-1 immunogens. Here, we propose to use a novel functional proteomics approach to analyze HIV-1-specific CD8+ T cells on the level of post-TCR signaling. Our overall hypothesis is that the analysis of TCR-triggered phosphorylation of signal transduction proteins (kinomics) allows for identifying HIV-1-specific CD8+ T cells associated with a protective CD8+ T cell response against HIV-1. To test this hypothesis, we will compare TCR signaling between HLA-A2- restricted HIV-specific CD8+ T cells and A2-restricted CD8+ T cells specific for immunologically-controlled viruses, such as CMV, EBV and Influenza virus, using a high-throughput multiplex reverse-phase protein microarray for screening purposes and flow cytometric assays with antibodies recognizing phosphorylated kinases for the in-depth analysis of signaling events on a single cell level (specific aim #1a). Moreover, we will analyze whether TCR signaling pathways differ between HI V-1-specific CD8+ T cells restricted by HLA- class I alleles associated with distinct HIV-1 disease outcomes (specific aim #1b). Finally, we will test whether specific clusters of post-TCR signaling pathways are associated with the execution of selected effector functions of HI V-1-specific CD8+ T cells (specific aim #2), again using microarray screening technology in combination with flow cytometry. These experiments will indicate whether specific functional characteristics of HI V-1-specific CD8+ T cells, such as cytokine secretion or cytotoxic properties, are associated with distinct signaling characteristics. Overall, our investigations will be relevant for defining key signaling networks of HI V-1-specific CD8+ T cells associated with protective immunity against HIV-1. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI068499-01
Application #
7062580
Study Section
AIDS Immunology and Pathogenesis Study Section (AIP)
Program Officer
Gupta, Kailash C
Project Start
2006-01-01
Project End
2007-12-31
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
1
Fiscal Year
2006
Total Cost
$218,750
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199